Increased Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 Expression Enhances Chemosensitivity in Glioma

Baohui Liu,Qianxue Chen,Daofeng Tian,Liquan Wu,Junmin Wang,Qiang Cai,Heng Shen,Baowei Ji,Long Wang,Shenqi Zhang,Dong Ruan,Xiaonan Zhu,Zhentao Guo,Huimin Dong,Mingmin Yan
DOI: https://doi.org/10.3969/j.issn.1673-5374.2011.32.007
2011-01-01
Neural Regeneration Research
Abstract:Leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) is an anti-oncogene. LRIG1 is correlated with Bcl-2 in ependymonnas. Decreased Bcl-2 and manganese superoxide dismutase expression can improve the chennosensitivity of glioma. In the present study, a tissue microarray of human brain astrocytomas was constructed. To investigate the relationship of LRIG1 with Bcl-2 and manganese superoxide dismutase, LRIG1, Bcl-2 and manganese superoxide dismutase expression in our tissue microarray was determined using immunohistochemistry. In addition, we constructed the LRIG1-U251 cell line, and its responses to doxorubicin and temozolomide were detected using the MTT assay. Results showed that LRIG1 expression was significantly negatively correlated with Bcl-2 and manganese superoxide dismutase expression in glioma. Also, proliferation of LRIG1-U251 cells exposed to doxorubicin or temozolomide was significantly inhibited, i.e. in the LRIG1-U251 cell line, the chemosensitivity to doxorubicin and temozolomide was increased. This indicates that increased LRIG1 expression produces a chemosensitivity in glioma.
What problem does this paper attempt to address?